Bayesian PAH Risk Stratification for Adult and Pediatric Patients
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing risk stratification tools for pulmonary arterial hypertension (PAH) are imprecise, outdated, and fail to account for functional associations between diverse parameters, lacking versatility and customization for pediatric patients, leading to insufficient prognostic accuracy and treatment guidance.
Innovation Solution
A clinical decision support system (CDSS) employing Bayesian statistical analysis and machine learning, integrating imaging and genomic data, to provide individualized risk stratification and treatment guidance for both adult and pediatric PAH patients, utilizing the PHORA system and enhanced prognostic models.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional statistical methods and established clinical variables are used for risk stratification, then the approach is simple and widely applicable, but the precision and accuracy of risk prediction is insufficient
Solution Approach 1:
The patent transforms traditional clinical variables into a probabilistic framework using Bayesian networks, changing the mathematical representation from deterministic to probabilistic parameters. This allows the system to capture uncertainty and functional associations between variables, improving risk prediction accuracy while maintaining clinical interpretability
Solution Approach 2:
The system integrates multiple data types (clinical variables, biomarkers, imaging data, genomic fingerprints) into a composite probabilistic model. This composite approach combines diverse information sources to achieve superior prediction accuracy compared to single-modality models
2Reliability
If probabilistic risk models are used to account for functional associations between parameters, then the prognostic accuracy improves, but the complexity of the model increases
Solution Approach 1:
The Bayesian network structure serves as an intermediary framework that formally represents functional associations between clinical parameters. The graphical model structure acts as a mediator that encodes conditional dependencies, allowing the system to capture complex relationships without requiring explicit mathematical formulations for each interaction
3Adaptability or versatility
If existing risk stratification tools are used, then they provide a basis for clinical decision-making, but they lack versatility and customization for different patient populations including pediatrics
Solution Approach 1:
The Bayesian network framework provides a universal probabilistic structure that can be applied across different patient populations. The same fundamental model architecture serves multiple functions by adapting to adult and pediatric populations through population-specific parameter calibration and variable selection, rather than requiring entirely separate models
Data Source
AI summary
A clinical decision support system and method for patients with pulmonary arterial hypertension is disclosed herein. The system may comprise a processor to process instructions to execute one or more pulmonary arterial hypertension risk algorithms configured to generate a risk score value associated with a patient surviving within a given time period. The system may comprise a means for input and output, wherein input variable data may be received and a set of risk score values may be displayed. A method for operating the clinical decision support system is also disclosed.